Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Prime Medicine Inc (NASDAQ: PRME) closed at $2.73 in the last session, up 10.53% from day before closing price of $2.47. In other words, the price has increased by $10.53 from its previous closing price. On the day, 3.62 million shares were traded. PRME stock price reached its highest trading level at $2.78 during the session, while it also had its lowest trading level at $2.28.
Ratios:
We take a closer look at PRME’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.07.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 30 ’25 when Liu David R. bought 21,000 shares for $2.52 per share. The transaction valued at 52,830 led to the insider holds 20,240,945 shares of the business.
Liu David R. bought 21,000 shares of PRME for $45,402 on Jun 23 ’25. The 10% Owner now owns 20,219,945 shares after completing the transaction at $2.16 per share. On Jun 16 ’25, another insider, Liu David R., who serves as the 10% Owner of the company, bought 21,000 shares for $1.49 each. As a result, the insider paid 31,196 and bolstered with 20,198,945 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 358432608 and an Enterprise Value of 292615136. For the stock, the TTM Price-to-Sale (P/S) ratio is 93.10 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 76.083 whereas that against EBITDA is -1.463.
Stock Price History:
The Beta on a monthly basis for PRME is 2.34, which has changed by -0.48876405 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, PRME has reached a high of $6.75, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 69.88%, while the 200-Day Moving Average is calculated to be 4.01%.
Shares Statistics:
According to the various share statistics, PRME traded on average about 2.41M shares per day over the past 3-months and 4615480 shares per day over the past 10 days. A total of 131.16M shares are outstanding, with a floating share count of 51.66M. Insiders hold about 60.65% of the company’s shares, while institutions hold 28.66% stake in the company. Shares short for PRME as of 1749772800 were 18480703 with a Short Ratio of 7.67, compared to 1747267200 on 17703437. Therefore, it implies a Short% of Shares Outstanding of 18480703 and a Short% of Float of 27.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
